Genenta Science
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GNTA and buy or sell other stocks, ETFs, and their options commission-free!About GNTA
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload.
CEOPierluigi Paracchi
CEOPierluigi Paracchi
Employees9
Employees9
HeadquartersMilan, Milan
HeadquartersMilan, Milan
Founded2014
Founded2014
Employees9
Employees9
GNTA Key Statistics
Market cap16.50M
Market cap16.50M
Price-Earnings ratio-1.97
Price-Earnings ratio-1.97
Dividend yield—
Dividend yield—
Average volume45.67K
Average volume45.67K
High today$0.75
High today$0.75
Low today$0.70
Low today$0.70
Open price$0.75
Open price$0.75
Volume39.43K
Volume39.43K
52 Week high$10.00
52 Week high$10.00
52 Week low$0.59
52 Week low$0.59
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.